🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2026

Annual patent cliff calendar for 2026 — US pharmaceutical patents by expiration date.

Patents
360

Quick answer

360 indexed pharmaceutical patents have expiration dates in 2026. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7060824

    Pyrrolotriazolopyrimidinone derivatives

    Almirall Prodesfarma S.A. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7060259

    Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)

    Nektar Therapeutics AL, Corporation · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7060689

    Methods and compositions for delivery and retention of active agents to lymph nodes

    The Board of Regents of the University of Texas System · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7060466

    Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene

    The Board of Regents of the University of Oklahoma · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7060276

    Plasmodium falciparum AMA-1 protein and uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7060688

    Products and methods for controlling the suppression of the neoplastic phenotype

    The Regents of the University of California · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7061237

    Remote NMR/MRI detection of laser polarized gases

    The Regents of the University of California · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7060686

    Anti-inflammatory compounds derived from Pseudopterogorgia elisabethae

    The Regents of the University of California · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7060733

    Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxygen species

    The Regents of the University of California · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7060113

    Hair coloring composition and method

    HairMarker LLC · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7060442

    Modulators on Nod2 signaling

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7060827

    Intermediates useful for making 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7060703

    Indolinone derivatives

    Theravance, Inc. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7060837

    Method for the purification of lansoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7060672

    Cyclosporin analog formulations

    Isotechnika, Inc. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7060256

    Increased peroxide content tooth bleaching gel

    DISCUS DENTAL, LLC · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7060712

    Crystalline form of aryl aniline β2 adrenergic receptor agonist

    Theravance, Inc. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7064141

    Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7063847

    Compositions and methods for enhancing immune responses mediated by antigen-presenting cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7064106

    Gene and use thereof

    Takeda Chemical Industries Ltd. · Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7063840

    TIE-2 ligands, methods of making and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7064181

    Physiologically active peptide and its use

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7064112

    Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

    CAN-FITE BIOPHARMA LTD. · Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7067537

    Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7067483

    Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin

    Theravance, Inc. · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7067481

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7067317

    Regulation of angiogenesis with zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7067256

    Ribozyme mediated inactivation of the androgen receptor

    The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7067122

    Modified live Edwardsiella tarda vaccine for aquatic animals

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7067546

    Crystal and process for producing the same

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7067111

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7067254

    Diagnosis and treatment of inflammation and hyperactive immune conditions

    The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7067635

    Nucleotide and deduced amino acid sequences of tumor gene Int6

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7067482

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7067527

    Thienopyridine derivatives, their production and use

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7067620

    Antibacterial agents

    Theravance, Inc. · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7067109

    Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7067653

    Porphyrin Based neuton capture agents for cancer therapy

    The Regents of the University of California · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7067661

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7067633

    Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells

    The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7067318

    Methods for transfecting T cells

    United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7071224

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7071205

    5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7071200

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7071168

    Anti-cancer compounds and methods related thereto

    The Regents of the University of Colorado · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7070975

    Protein and DNA thereof

    Takeda Chemical Industries Ltd. · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7070973

    Butyrylcholinesterase variants and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7070972

    Janus family kinases and identification of immune modulators

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2026?

360 published patents in our USPTO index have expiration dates falling in calendar year 2026.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.